{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:21:31Z","timestamp":1726446091148},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,15]]},"DOI":"10.7759\/cureus.69468","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T21:21:48Z","timestamp":1726435308000},"source":"Crossref","is-referenced-by-count":0,"title":["Secondary CNS Lymphoma in an Immunocompromised Patient: A Diagnostic Dilemma"],"prefix":"10.7759","author":[{"given":"Muhammad Qasim","family":"Naeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Atif","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambar","family":"Ambreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Asad Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1004-0002","article-title":"Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities","volume":"11","author":"Wong ET","year":"2005","unstructured":"Wong ET. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities. Clin Cancer Res. 2005, 11:7151s-7s. 10.1158\/1078-0432.CCR-1004-0002","journal-title":"Clin Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S157959","article-title":"Secondary central nervous system lymphoma: spectrum of morphological MRI appearances","volume":"14","author":"Malikova H","year":"2018","unstructured":"Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J. Secondary central nervous system lymphoma: spectrum of morphological MRI appearances. Neuropsychiatr Dis Treat. 2018, 14:733-40. 10.2147\/NDT.S157959","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hegde U","year":"2005","unstructured":"Hegde U, Filie A, Little RF, et al.. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood. 2005, 105:496-502. 10.1182\/blood-2004-05-1982","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group","volume":"27","author":"Bernstein SH","year":"2009","unstructured":"Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI. Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group. J Clin Oncol. 2009, 27:114-9. 10.1200\/JCO.2008.16.8021","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill QA","year":"2006","unstructured":"Hill QA, Owen RG. CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev. 2006, 20:319-32. 10.1016\/j.blre.2006.02.001","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2005.05.008","article-title":"Secondary central nervous system lymphoma: risk factors and prophylaxis","volume":"19","author":"Montoto S","year":"2005","unstructured":"Montoto S, Lister TA. Secondary central nervous system lymphoma: risk factors and prophylaxis. Hematol Oncol Clin North Am. 2005, 19:751-63, viii. 10.1016\/j.hoc.2005.05.008","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen IS","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011, 32:984-92. 10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp432","article-title":"Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy","volume":"21","author":"Villa D","year":"2010","unstructured":"Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol. 2010, 21:1046-52. 10.1093\/annonc\/mdp432","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2016.04.004","article-title":"The multiple faces of nervous system lymphoma. Atypical magnetic resonance imaging features and contribution of the advanced imaging","volume":"46","author":"Jim\u00e9nez de la Pe\u00f1a MD","year":"2017","unstructured":"Jim\u00e9nez de la Pe\u00f1a MD, Vicente LG, Alonso RC, Cabero SF, Su\u00e1rez AM, de Vega VM. The multiple faces of nervous system lymphoma. Atypical magnetic resonance imaging features and contribution of the advanced imaging. Curr Probl Diagn Radiol. 2017, 46:136-45. 10.1067\/j.cpradiol.2016.04.004","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.25259\/JCIS_135_2021","article-title":"Different facets of intracranial central nervous system lymphoma and its imaging mimics","volume":"12","author":"Kwok HM","year":"2022","unstructured":"Kwok HM, Li KY, Chan RL, et al.. Different facets of intracranial central nervous system lymphoma and its imaging mimics. J Clin Imaging Sci. 2022, 12:4. 10.25259\/JCIS_135_2021","journal-title":"J Clin Imaging Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2016.03.005","article-title":"Neuroimaging in central nervous system lymphoma","volume":"30","author":"Nabavizadeh SA","year":"2016","unstructured":"Nabavizadeh SA, Vossough A, Hajmomenian M, Assadsangabi R, Mohan S. Neuroimaging in central nervous system lymphoma. Hematol Oncol Clin North Am. 2016, 30:799-821. 10.1016\/j.hoc.2016.03.005","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.14092","article-title":"Imaging of nervous system involvement in hematologic malignancies: what radiologists need to know","volume":"205","author":"Keraliya AR","year":"2015","unstructured":"Keraliya AR, Krajewski KM, Giardino AA, Tirumani SH, Shinagare AB, Ramaiya NH, Jagannathan JP. Imaging of nervous system involvement in hematologic malignancies: what radiologists need to know. AJR Am J Roentgenol. 2015, 205:604-17. 10.2214\/AJR.14.14092","journal-title":"AJR Am J Roentgenol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.7266","article-title":"Extranodal lymphoma from head to toe: part 1, the head and spine","volume":"197","author":"Thomas AG","year":"2011","unstructured":"Thomas AG, Vaidhyanath R, Kirke R, Rajesh A. Extranodal lymphoma from head to toe: part 1, the head and spine. AJR Am J Roentgenol. 2011, 197:350-6. 10.2214\/AJR.10.7266","journal-title":"AJR Am J Roentgenol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292512-secondary-cns-lymphoma-in-an-immunocompromised-patient-a-diagnostic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T21:21:51Z","timestamp":1726435311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292512-secondary-cns-lymphoma-in-an-immunocompromised-patient-a-diagnostic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,15]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.69468","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,15]]}}}